Health Impact Report - Medical Equipment & Supplies Edition

In our latest quarterly review of corporate sustainability impacts, risks and opportunities, we find that medical equipment companies face significant financial impacts from increasing regulatory pressure, with policy emphasis on access, affordability and quality growing globally. The report identifies that half the global population has limited or no access to diagnostics and reducing this gap for six conditions could prevent 1.1 million premature deaths annually in low-income countries. Leading firms are implementing fair pricing strategies and collaborating with partners to address value chain challenges while balancing financial materiality with broader impact materiality considerations.

This report analyses thousands of sustainability disclosures from 20 leading entities in the industry, including Abbott Laboratories, GE HealthCare Technologies and Medtronic. Published in Q225 as part of a quarterly series, it also includes disclosures from Global South entities like Tata Medical and Diagnostics, Bharat Biotech and Mindray Medical International. The global nature of this analysis makes it an ideal source of external evidence for sustainability accounting and disclosure, particularly for organisations implementing the European Union's Medical Device Regulation and integrating ESG objectives into affordability initiatives.